Catalyst Wire Dossier Catalyst Wire Dossier

VLA-1553 vaccine

VLA-1553 · Valneva Austria GmbH
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for VLA-1553 vaccine, covering 2026-02-11 to 2026-02-11. Get the full timeline:

Most recent: Clinical Trial Update: Observational Study to Assess the Effectiveness of VLA1553 Vaccine in Preventing Chikungunya During a Pilot Vaccination Strategy in Brazil

See pricing